Cas No.: 500577-51-5
PRODUCT INFORMATION
Description
Cyclo(-RGDfK) (Cyclo[Arg-Gly-Asp-D-Phe-Lys]) is a potent (IC50 = 0.94 nM) and selective inhibitor of the αvβ3 integrin. It is known to effectively bind to both tumor microvasculature and cancer cell lines in vitro by specifically interacting with cell-surface αvβ3 integrin. It is a foundational tool for research into integrin-mediated signaling and adhesion.
Molecular Weight
717.69
Purity
> 95%
Formula
C₂₉H₄₂F₃N₉O₉
Product Type
Targeting Peptide
Sequence
Cyclo[Arg-Gly-Asp-D-Phe-Lys]
Form (20 deg.C)
Solid
Storage Condition
Store sealed at -20°C, away from moisture.
For Research Use Only | Not For Clinical Use
Related products
- Bonemarrow-Derived Mesenchymal Stem Cells Affinity Peptide (CAT#: OLY-1025-YS-44)
- Cyclo(RGDfK(Mal)) Targeting Peptide (CAT#: OLY-1025-YS-46)
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- 3BP-4089 TFA Targeting Peptide (CAT#: OLY-1025-YS-56)
- Breast Cancer Targeting Peptide 18-4 (CAT#: OLY-1025-YS-23)
- VSLRGDTRG Targeting Peptide (CAT#: OLY-1025-YS-32)
- NGR Peptide TFA (CAT#: OLY-1025-YS-59)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.